These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7855691)
1. [Treatment with oral anticoagulants (acenocoumarol): influence of the initial doses in the incidence of hemorrhagic and thromboembolic episodes]. Amian A; Rodríguez JN; Muñiz R; Diéguez JC; Cañavate M; Fernández-Jurado A; Martino ML; Prados D Sangre (Barc); 1994 Dec; 39(6):413-6. PubMed ID: 7855691 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)]. Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047 [TBL] [Abstract][Full Text] [Related]
3. [Hemorrhagic complications in patients treated with oral anticoagulants]. Amian A; Rodríguez JN; Diéguez JC; Cañavate M; Fernández A; Martino ML; Muñiz R; Prados D Sangre (Barc); 1993 Oct; 38(5):349-53. PubMed ID: 8140495 [TBL] [Abstract][Full Text] [Related]
4. [Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients]. Selva O'Callaghan A; San José Laporte A; Fuentes Camps I; Nicolau Fuste J; Piqueras Carrasco J; Vilardell Tarres M Rev Clin Esp; 1997 May; 197(5):323-8. PubMed ID: 9280965 [TBL] [Abstract][Full Text] [Related]
5. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol]. Reverter JC; Tàssies D; Maragall S; Monteagudo J; Escolar G; Ordinas A Med Clin (Barc); 1995 Jun; 105(4):127-30. PubMed ID: 7623503 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial. Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850 [TBL] [Abstract][Full Text] [Related]
7. [Risk of chronic oral anticoagulant treatment in elderly patients]. Braun S; Chamorro G; Wilson C; Casanegra P; Corbalán R; Iirarrázaval MJ; Kobus C; Valle I Rev Med Chil; 1992 May; 120(5):552-8. PubMed ID: 1343069 [TBL] [Abstract][Full Text] [Related]
8. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157 [TBL] [Abstract][Full Text] [Related]
9. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy. Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097 [TBL] [Abstract][Full Text] [Related]
10. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739 [TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients. Mazokopakis EE; Vrentzos GE; Ganotakis ES Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529 [TBL] [Abstract][Full Text] [Related]
14. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
16. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic. Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920 [TBL] [Abstract][Full Text] [Related]
17. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial. Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326 [TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial. Vetrano A; Milani M; Corsini G G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219 [TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920 [TBL] [Abstract][Full Text] [Related]
20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]